https://rxbriefing.comPharma, biotech, medtech and health AI stock newshttps://www.fiercehealthcare.com/regulatory/senators-express-concerns-over-new-uspstf-appointments-seek-information-rfk-jra1eb349dce5cSun, 11 Oct 2026 03:12:13 +0000The lawmakers expressed concerns over the panel’s ability to make recommendations, the transparency of the application process and more.https://www.fiercehealthcare.com/ai-and-machine-learning/utah-taps-august-ai-nolla-health-healthcare-ai-sandbox-program-adds-third82a1b85c1286Sun, 11 Oct 2026 03:12:13 +0000Utah is expanding the state's AI regulatory sandbox program with new pilots to test AI-supported prescription renewals, dermatology and physical therapy, while adding physician oversight and independent third-party evaluators.https://www.fiercehealthcare.com/health-tech/general-medicine-banks-120m-backed-a16z-eli-lilly-and-mercy-health66bcb2e965bfSun, 11 Oct 2026 03:12:13 +0000General Medicine, started by the founding team that built PillPack and Amazon Pharmacy, is an online marketplace where customers can search, compare and buy care, see insurance and cash prices before deciding, and get guidance from a…https://www.fiercehealthcare.com/payers/cigna-unveils-new-customer-experience-platform-health-sense1149a2e4b76eSun, 11 Oct 2026 03:12:13 +0000Cigna is rolling out a new patient experience platform that aims to harness the power of data to drive greater personalization.https://www.fiercehealthcare.com/providers/after-ice-raids-hospitals-saw-fewer-ed-visits-more-admissions-among-foreign-born-study7908936adaacSun, 11 Oct 2026 03:12:13 +0000Studies published this week outline changes in care-seeking behavior tied to heightened federal immigration policy and rhetoric, with ramifications for patient outcomes and healthcare spending.https://www.fiercehealthcare.com/providers/kaiser-permanente-repay-nurses-potentially-tens-millions-mistakenly-withheld-wagesf48d39b018baSun, 11 Oct 2026 03:12:13 +0000Following an arbitration agreement, more than 1,000 nurses will be compensated for a payment error that began in 2021, the California Nurses Association said. The major nonprofit confirmed the plans but did not comment on the total amount.https://www.fiercehealthcare.com/pharma/phrma-launches-new-legal-challenge-cms-brings-most-favored-nation-pricing-medicare-part-b7be579e8eccaSun, 11 Oct 2026 03:12:13 +0000As the Trump administration advances plans to bring its “most favored nation” drug pricing model to Medicare Part B, the pharmaceutical industry’s top lobbying group is pushing back in court.https://www.fiercehealthcare.com/finance/healthleap-banks-38m-funding-backed-sequoia-capital-first-round-capital-and-hummingbirda8ee73d0e6f5Sun, 11 Oct 2026 03:12:13 +0000Healthleap says its platform is the first and only validated AI malnutrition screening tool that contains EHR-integrated screening layers, executives say.https://www.fiercehealthcare.com/ai-and-machine-learning/suki-launches-ask-feature-clinical-decision-support-driven-wolters-kluwer362b5fdee4c4Sun, 11 Oct 2026 03:12:13 +0000Ask integrates evidence-based clinical reasoning directly into workflows and can provide answers grounded in UpToDate’s proprietary content.https://www.fiercehealthcare.com/health-tech/fierce-healthcare-fundraising-tracker-2694e71ae2762bSun, 11 Oct 2026 03:12:13 +0000Keep up with all the venture capital dollars being funneled into the health tech and digital health industries.https://www.fiercehealthcare.com/payers/michigan-ag-hits-bcbsm-antitrust-suitb877811122f8Sun, 11 Oct 2026 03:12:13 +0000Michigan Attorney General Dana Nessel has filed suit against Blue Cross Blue Shield of Michigan, alleging that the insurer operated as a monopoly in the state.https://www.fiercehealthcare.com/providers/chutes-ladders-2026-hires-departures-firings-retirements-ceo-executives-healthcare1c76bd9fe64fSun, 11 Oct 2026 03:12:13 +0000Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the good news—or the bad—from your shop, and we will feature it here at the end of each week.https://www.fiercehealthcare.com/regulatory/hhs-340b-expanded-beyond-its-original-intent-incentivizes-consolidation8e0985111175Sun, 11 Oct 2026 03:12:13 +0000A new brief lays out the administration's views and critiques of the controversial hospital subsidy program, and includes a data analysis suggesting that a proposed reimbursement cut will limit spending growth.https://www.fiercehealthcare.com/regulatory/hhs-launches-4-new-vaccine-injury-research-reporting-initiatives39b7ec1c0f31Sun, 11 Oct 2026 03:12:13 +0000The U.S. Department of Health and Human Services (HHS) on Thursday announced a series of actions aimed at strengthening the federal government's response to vaccine-related health concerns.https://www.fiercehealthcare.com/payers/cms-about-71-mapd-plan-enrollees-coverage-four-or-more-stars-20276f996067c778Sun, 11 Oct 2026 03:12:13 +0000The Trump administration has released the 2027 Medicare Advantage star ratings, with many enrollees in plans that earned at least four stars.https://www.fiercehealthcare.com/regulatory/look-stakeholder-perspectives-medicare-advantage-reformca02f690737aSun, 11 Oct 2026 03:12:13 +0000A survey of 52 experts spanning researchers, the Medicare Advantage industry, patient advocates and policymakers wasn't able to identify a single policy proposal that would be received wholeheartedly by all three groups.https://www.fiercehealthcare.com/providers/hospital-closures-accelerated-2010-rates-similar-among-rural-urban-facilitiesa6b1e84b9134Sun, 11 Oct 2026 03:12:13 +0000There were 432 acute hospital closures and 216 openings across the country from 2010 through 2025, with the former accelerating over time and the latter slowing, according to a new study. Closure rates were statistically similar between…https://www.fiercehealthcare.com/payers/humana-rebounds-aetna-slips-winners-and-losers-2027-ma-star-ratings560eaf76c10fSun, 11 Oct 2026 03:12:13 +0000Federal regulators released the hotly anticipated star ratings for the 2027 Medicare Advantage plan year, and winners and losers emerged in the data.https://www.fiercehealthcare.com/providers/hospital-industry-files-lawsuit-block-hhs-340b-rebate-pilot-again135defc7c0acSun, 11 Oct 2026 03:12:13 +0000The American Hospital Association and others have launched a legal rematch with the federal government over the second iteration of a pilot program swapping out safety-net hospitals’ upfront drug discounts for after-the-fact rebates.https://www.fiercehealthcare.com/ai-and-machine-learning/abridge-university-texas-system-enter-enterprise-wide-agreement-expanded-ai683d574aabbbSun, 11 Oct 2026 03:12:13 +0000The partnership establishes a systemwide framework for the eight UT health institutions to access Abridge.https://www.fiercehealthcare.com/health-tech/weekly-rundown-hhs-awards-15m-ai-projects-arcadia-launches-portfolio-solutions9f79860ff66cSun, 11 Oct 2026 03:12:13 +0000The latest news from Nextech, Assort Health, EliseAI, Elsevier, Arcadia, Solera Health and more.https://www.fiercehealthcare.com/regulatory/fierce-healthcare-regulatory-recap-cms-releases-2027-ma-star-ratings-hhs-launches40485064a721Sun, 11 Oct 2026 03:12:13 +0000The latest news from CMS, HHS and more across Washington, D.C.https://www.fiercehealthcare.com/finance/industry-voices-why-health-system-cfos-cant-budget-their-way-out-coverage-disruptiond8874697108bSun, 11 Oct 2026 03:12:13 +0000Semi-annual redeterminations and work requirements will test payer-mix assumptions across the industry over the next two years. Now is the time for health systems to prepare, writes Ensemble SVP Matthew Ennen.https://www.fiercehealthcare.com/health-tech/oracle-health-data-breach-2025-compromised-data-20m-people-reporta2b4c9333823Sun, 11 Oct 2026 03:12:13 +0000In a report issued October 2, the Texas attorney general said the company disclosed that Social Security numbers, addresses and medical information of almost 20 million people, including about 3 million Texans, Bloomberg reported.https://www.fiercehealthcare.com/regulatory/rep-pallone-introduces-bill-replacing-no-surprises-acts-arbitration-process6c0e3876acadSun, 11 Oct 2026 03:12:13 +0000One of the No Surprises Act’s chief authors wants to replace the "broken" system for settling out-of-network pay disputes with market-based benchmarks.https://www.fiercepharma.com/pharma/psychedelics-scale-uncertainty-baked-sauce-developers-experts-opine367d4641c603Sun, 11 Oct 2026 03:12:13 +0000The possibility of psychedelic therapies for PTSD or treatment-resistant depression in the U.S. has never been greater. But even as the industry inches closer to an FDA go-ahead, the realities of approved psychedelic medicine are far from…https://www.fiercepharma.com/pharma/how-drugmakers-are-tapping-glp-1-frenzys-unprecedented-consumer-overlayf9406352900bSun, 11 Oct 2026 03:12:13 +0000With the advent of powerful GLP-1 medications from Novo and Eli Lilly, the conversation about obesity as a chronic disease has begun to shift, along with the understanding of how tackling weight can trigger a multitude of downstream…https://www.fiercepharma.com/manufacturing/national-fragility-index-spotlights-prescriptions-vulnerable-supply-chain-problemsa8cb38113e43Sun, 11 Oct 2026 03:12:13 +0000The National Fragility Index, launched by the API Innovation Center, warned that more than 550 million prescriptions filled in the U.S. in 2023 were categorized as being highly or severely vulnerable to supply chain interruptions.https://www.fiercepharma.com/pharma/halozyme-stymies-subq-keytruda-launch-select-european-countries-merck-vows-fight-patent4d6c9f41f87dSun, 11 Oct 2026 03:12:13 +0000After facing a setback in Germany late last year, Merck & Co.’s European marketing plans for its below-the-skin Keytruda SC are growing more complicated.https://www.fiercepharma.com/pharma/novartis-rhapsido-tackles-2-most-common-forms-chronic-swift-fda-expansion268e45896d8aSun, 11 Oct 2026 03:12:13 +0000A little over a year after landing its flagship approval in chronic hives, Novartis’ oral BTK inhibitor Rhapsido is expanding its reach with a new FDA nod that comes with a notable ‘first’ for the field.https://www.fiercepharma.com/marketing/sanofi-drafts-ny-knicks-star-karl-anthony-towns-covid-nuvaxovid-awareness-push7c34e2be24d4Sun, 11 Oct 2026 03:12:13 +0000New York Knicks champ Karl-Anthony Towns is sharing his personal experience with COVID to encourage others to talk with their doctors about vaccination options.https://www.fiercepharma.com/pharma/phrma-launches-new-legal-challenge-cms-brings-most-favored-nation-pricing-medicare-part-b1848c39acceaSun, 11 Oct 2026 03:12:13 +0000As the Trump administration advances plans to bring its “most favored nation” drug pricing model to Medicare Part B, the pharmaceutical industry’s top lobbying group is pushing back in court.https://www.fiercepharma.com/pharma/theramex-pays-250m-rights-asieris-first-kind-cervical-lesion-treatmentd5e53c368476Sun, 11 Oct 2026 03:12:13 +0000Should an EU approval go through, the deal allows Asieris to piggyback its global expansion on Theramex’s established women’s health infrastructure across Europe.https://www.fiercepharma.com/marketing/melissa-explains-it-all-menopause-team-bayera85217937561Sun, 11 Oct 2026 03:12:13 +0000Bayer is teaming up with American actress and director Melissa Joan Hart to boost awareness about hot flashes treatment Lynkuet by tapping her personal experiences.https://www.fiercepharma.com/marketing/csl-seqirus-blasted-multiple-and-prolonged-deficiencies8df7aa9b190eSun, 11 Oct 2026 03:12:13 +0000A U.K. drug marketing watchdog has slammed CSL Seqirus for “multiple and prolonged deficiencies” in its systems, governance and oversight.https://www.fiercepharma.com/pharma/argenx-walks-away-vyvgart-sjogrens-disease-trial-after-futility-flag4887bbbea72eSun, 11 Oct 2026 03:12:13 +0000Just shy of two months after teeing up its FcRn blocker Vyvgart Hytrulo for entry into another potential immunology niche, argenx has stumbled in a late-stage trial testing the drug against a separate target.https://www.fiercepharma.com/pharma/viatris-buyout-paciras-pain-pipeline-165b40af162d8945Sun, 11 Oct 2026 03:12:13 +0000In a push to up its investments in patent-protected medicines, Viatris is set to acquire Pacira BioSciences, including two high-margin non-opioid pain therapies.https://www.fiercepharma.com/pharma/pfizers-tukysa-snags-first-line-approval-her2-breast-cancer6b49cc18975eSun, 11 Oct 2026 03:12:13 +0000Pfizer bagged a coveted first-line maintenance approval for Tukysa. In combination with HER2 antibody drugs, the treatment can significantly delay disease progression for patients with advanced breast cancer.https://www.fiercepharma.com/pharma/bms-fills-out-zenbexus-picture-post-approval-pfs-victory-multiple-myeloma5e3982af61e4Sun, 11 Oct 2026 03:12:13 +0000BMS has put up the progression-free survival numbers on its recently approved Zenbexus regimen, more than doubling the score over a control cocktail of daratumumab, bortezomib and dexamethasone.https://www.fiercepharma.com/regulatory/hhs-launches-4-new-vaccine-injury-research-reporting-initiativesead21c2b42c5Sun, 11 Oct 2026 03:12:13 +0000The U.S. Department of Health and Human Services (HHS) on Thursday announced a series of actions aimed at strengthening the federal government's response to vaccine-related health concerns.https://www.fiercepharma.com/marketing/pharmas-free-lunches-clinicians-bloat-prescription-bills-cochrane-review87ad4068ab92Sun, 11 Oct 2026 03:12:13 +0000Promotional interactions between clinicians and pharmaceutical companies are probably associated with harmful outcomes, according to a Cochrane review that assessed free meals, ads and other dealings.https://www.fiercepharma.com/pharma/novartis-78b-mrna-deal-shionogi-2b-buy-arrivent-phase-3-flop1d170a49dad8Sun, 11 Oct 2026 03:12:13 +0000Novartis bought an mRNA-coded autoimmune T-cell engager candidate for up to $7.8 billion, as Shionogi offered $2 billion to acquire rare disease drugmaker IntraBio. ArriVent's EGFR inhibitor flunked a first-line phase 3 test in lung…https://www.fiercepharma.com/pharma/teva-debuts-weltruza-schizophrenia-much-hyped-fda-nod-long-acting-olanzapine-arrives8976864cab70Sun, 11 Oct 2026 03:12:13 +0000With a Friday go-ahead from the FDA, another key piece of Teva’s innovation revamp strategy has fallen into place, further bolstering the drugmaker’s footing in schizophrenia.https://www.fiercepharma.com/pharma/quince-relaunches-irulya-going-all-lung-disease-after-hail-mary-mergerd8edc0b0f4baSun, 11 Oct 2026 03:12:13 +0000To close the book on a tumultuous year, San Francisco's Quince will now operate under the name IRulya Therapeutics, becoming laser-focused on advancing LAM-001, an investigational inhaled formulation of rapamycin being tested in multiple…https://www.fiercepharma.com/providers/hospital-industry-files-lawsuit-block-hhs-340b-rebate-pilot-again08373ac688b3Sun, 11 Oct 2026 03:12:13 +0000The American Hospital Association and others have launched a legal rematch with the federal government over the second iteration of a pilot program swapping out safety-net hospitals’ upfront drug discounts for after-the-fact rebates.https://www.fiercepharma.com/pharma/fda-rasonque-review-documents-pressure-revmed-investors-jitter-over-kras-subgroup-data683da01937d8Sun, 11 Oct 2026 03:12:13 +0000Revolution Medicines’ stock slid Thursday after newly released FDA review documents sparked investor unease around Rasonque’s market position in a key KRAS subgroup.https://www.fiercepharma.com/pharma/oral-glp-1-tracker-launch-trajectories-lilly-foundayo-novo-wegovy-pill12f3086c234cSun, 11 Oct 2026 03:12:13 +0000Fierce Pharma is launching the weekly Oral GLP-1 Tracker, leveraging analysts’ notes and IQVIA data to monitor prescription trends and shifting market shares as Novo Nordisk's Wegovy pill and Eli Lilly's Foundayo vie to become the go-to…https://www.fiercepharma.com/pharma/fierce-pharma-regulatory-tracker-2026-h231ea1caa5157Sun, 11 Oct 2026 03:12:13 +0000In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they…https://www.fiercepharma.com/pharma/gsk-commits-800m-rd-manufacturing-hub-pennsylvania-bonds-deepenfb4189d58bf6Sun, 11 Oct 2026 03:12:13 +0000As GSK works on a nearly $1 billion expansion at one wing of its Pennsylvania operations, the U.K.-headquartered Big Pharma is unveiling a similarly sized outlay to soup up another site across the state.https://www.fiercepharma.com/pharma/arcutis-zoryve-sticks-landing-gymnast-simone-biles-joining-new-awareness-campaign98e02a1602abSun, 11 Oct 2026 03:12:13 +0000World Champion gymnast Simone Biles is a Zoryve user herself, advocating for long-term treatment for conditions such as seborrheic dermatitis and atopic dermatitis.